Aktienbewertung
Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Roche Holding SWX:ROG |
228,50 Mrd. | -0,16 % | 3/6 | 4,19 % | 11,22 % | 9,36 % | UP |
|
Amgen NasdaqGS:AMGN |
149,94 Mrd. | 7,74 % | 5/6 | 6,49 % | 14,85 % | 12,02 % | DOWN |
|
Sanofi ENXTPA:SAN |
97,90 Mrd. | 3,03 % | 5/6 | 8,88 % | 15,97 % | 35,15 % | DOWN |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
99,62 Mrd. | 7,41 % | 4/6 | 119,40 % | 1,13 % | 23,02 % | DOWN |
|
Bristol-Myers Squibb NYSE:BMY |
95,97 Mrd. | 0,20 % | 5/6 | 63,65 % | 19,03 % | 8,17 % | DOWN |
|
CSL ASX:CSL |
102,19 Mrd. | 9,75 % | 4/6 | 6,37 % | 45,27 % | 36,27 % | DOWN |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
61,52 Mrd. | 54,83 % | 4/6 | 55,65 % | -56,08 % | -4,33 % | UP |
|
Takeda Pharmaceutical Company TSE:4502 |
7.100,82 Mrd. | 10,31 % | 4/6 | 44,96 % | -2,52 % | 12,19 % | UP |
|
Daiichi Sankyo Company TSE:4568 |
6.581,95 Mrd. | 17,17 % | 4/6 | 10,08 % | 55,01 % | 57,48 % | DOWN |
|
Bayer XTRA:BAYN |
27,54 Mrd. | -1,43 % | 2/6 | -4,28 % | 30,41 % | -3,67 % | UP |
|
Biogen NasdaqGS:BIIB |
20,91 Mrd. | -9,29 % | 1/6 | -2,32 % | 30,81 % | 12,19 % | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
17,92 Mrd. | 13,97 % | 4/6 | 12,17 % | -19,89 % | 21,51 % | UP |
|
Incyte NasdaqGS:INCY |
16,84 Mrd. | 2,79 % | 3/6 | 100,63 % | 28,87 % | -8,41 % | UP |
|
Hologic NasdaqGS:HOLX |
14,57 Mrd. | 8,27 % | 5/6 | 5,56 % | -1,36 % | 8,38 % | DOWN |
|
Neurocrine Biosciences NasdaqGS:NBIX |
14,01 Mrd. | 38,16 % | 4/6 | 11,95 % | 33,31 % | 20,35 % | UP |
|
Viatris NasdaqGS:VTRS |
11,94 Mrd. | -10,47 % | 3/6 | -9,88 % | -6,73 % | 7,42 % | UP |
|
Exelixis NasdaqGS:EXEL |
10,15 Mrd. | 14,74 % | 4/6 | 22,65 % | 10,88 % | 19,40 % | UP |
|
Swedish Orphan Biovitrum AB (publ) OM:SOBI |
93,61 Mrd. | 4,06 % | 4/6 | 16,03 % | 8,61 % | 29,92 % | DOWN |
|
Ionis Pharmaceuticals NasdaqGS:IONS |
10,20 Mrd. | -23,08 % | 0/6 | 46,92 % | -309,16 % | 9,41 % | UP |
|
Moderna NasdaqGS:MRNA |
9,46 Mrd. | 224,76 % | 2/6 | -45,93 % | 60,19 % | 25,46 % | DOWN |
